The DOI matches its Crossref record.
HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12
Abstract
KEERTI SHAH, NEAL NATHANSON; HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12, American Journal of Epidemiology, Volume 103, Issue 1, 1 January 1976, Pages 1–12, ht
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This included the contamination of poliovirus vaccine with Simian Virus 40 (SV40) 3 , for which the health impacts were not fully known for many decades 4 .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [3]
In the citing paper
“In the 20 th century several vaccine products were unintentionally contaminated with unwanted viruses during their production [1][2][3] .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [3]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Knowles, W. A., Pipkin, P. A., Andrews, N. J., Vyse, A., Minor, P. D., Brown, D., & Miller, E. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10450 · Cited by 581
Chesters, P. M., Heritage, J. C., & McCance, D. J. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.4.676 · Cited by 528
Live attenuated vaccines: Historical successes and current challenges
Minor, P. D. (2015) · Virology · doi:10.1016/j.virol.2015.03.032 · Cited by 494
Bergsagel, D. J., Finegold, M. J., Butel, J. S., Kupsky, W. J., & Garcea, R. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261504 · Cited by 406
Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease
Butel, J. S., & Lednicky, J. A. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.119 · Cited by 336
Cytological and cytogenetical studies on human meningioma
Zang, K. D. (1982) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(82)90063-2 · Cited by 278
Viral contamination in biologic manufacture and implications for emerging therapies
Barone, P. W., Wiebe, M. E., Leung, J. C., Hussein, I. T. M., Keumurian, F. J., Bouressa, J., Brussel, A., Chen, D., Chong, M., Dehghani, H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0507-2 · Cited by 212
Luca, A. D., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-913 · Cited by 209
Contamination of Poliovirus Vaccines With Simian Virus 40 (1955-1963) and Subsequent Cancer Rates
Strickler, H. D. (1998) · JAMA · doi:10.1001/jama.279.4.292 · Cited by 186
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Development of the choroid plexus
Dzięgielewska, K. M., Ek, C. J., Habgood, M. D., & Saunders, N. R. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010101)52:1 · Cited by 245
Carcinogenicity of malaria and of some polyomaviruses
Bouvard, V., Baan, R. A., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim‐Tallaa, L., Guha, N., & Straíf, K. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70125-0 · Cited by 145
Viscidi, R. P., Rollison, D. E. M., Viscidi, E., Clayman, B., Rubalcaba, E., Daniel, R. W., Major, E. O., & Shah, K. V. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.2.278-285.2003 · Cited by 143
Self-citationIs There a Role for SV40 in Human Cancer?
Poulin, D. L., & DeCaprio, J. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7101 · Cited by 143
Role of tight junctions in cell proliferation and cancer
González‐Mariscal, L., Lechuga, S., & Garay, E. (2007) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2007.01.001 · Cited by 137
Virus contaminations of cell cultures – A biotechnological view
Merten, O.-W. (2002) · Cytotechnology · doi:10.1023/a:1022969101804 · Cited by 133
Polyomaviruses and Human Diseases
Ahsan, N., & Shah, K. V. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_1 · Cited by 133
Self-citationInfectious Disease Issues in Xenotransplantation
Boneva, R. S., Folks, T. M., & Chapman, L. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.1-14.2001 · Cited by 133
History of Vaccine Development
Plotkin, S. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1339-5 · Cited by 131
Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer
Vilchez, R. A., & Butel, J. S. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.495-508.2004 · Cited by 127
SV40 and human cancer: A review of recent data
Shah, K. V. (2006) · International Journal of Cancer · doi:10.1002/ijc.22425 · Cited by 121
Self-citationBarbanti‐Brodano, G., Martini, F., Mattei, M. D., Lazzarin, L., Corallini, A., & Tognon, M. G. (1998) · Advances in virus research · doi:10.1016/s0065-3527(08)60806-4 · Cited by 118
The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease
Weiss, R. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0838 · Cited by 115
Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
Huang, H., Reis, R. M., Yonekawa, Y., Lopes, J. M., Kleihues, P., & Ohgaki, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00207.x · Cited by 113
Simian virus 40 infection in humans and association with human diseases: results and hypotheses
Barbanti‐Brodano, G., Sabbioni, S., Martini, F., Negrini, M., Corallini, A., & Tognon, M. G. (2004) · Virology · doi:10.1016/j.virol.2003.09.004 · Cited by 112
Long-Term Follow-up of Persons Inadvertently Inoculated with SV40 as Neonates
Mortimer, E. A., LEPOW, M. L., Gold, E., Robbins, F. C., Burton, G. J., & Fraumeni, J. F. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112173052507 · Cited by 105
Pathogenesis and Management of Polyomavirus Infection in Transplant Recipients
Kwak, E. J., Vilchez, R. A., Randhawa, P. S., Shapiro, R., Butel, J. S., & Kusne, S. (2002) · Clinical Infectious Diseases · doi:10.1086/344060 · Cited by 100
Simian Virus 40 Infection of Humans
Garcea, R. L., & Imperiale, M. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5039-5045.2003 · Cited by 98
Sauter, B. V., Parashar, B., Chowdhury, N. R., Kadakol, A., Ilan, Y., Singh, H. D., Milano, J., Strayer, D. S., & Chowdhury, J. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.19577 · Cited by 97
Pepper, C. J., Jasani, B., Navabi, H., Wynford‐Thomas, D., & Gibbs, A. R. (1996) · Thorax · doi:10.1136/thx.51.11.1074 · Cited by 96
Viruses and lymphoma/leukaemia
Jarrett, R. F. (2005) · The Journal of Pathology · doi:10.1002/path.1905 · Cited by 92
Engels, E. A., Katki, H. A., Nielsen, N. M., Winther, J. F., Hjalgrim, H., Gjerris, F., Rosenberg, P. S., & Frisch, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.532 · Cited by 91
Yang, G., Zhang, Z., Liao, J., Seril, D., Wang, L., Goldstein, S., & Yang, C. S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970904)72:5 · Cited by 38
Episomal simian virus 40 genomes in human brain tumors.
Krieg, P., Amtmann, E., Jonas, D., Fischer, H., Zang, K. D., & Sauer, G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6446 · Cited by 89
Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom
Mackenzie, J., Wilson, K. S., Perry, J., Gallagher, A., & Jarrett, R. F. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.1001 · Cited by 88
Rollison, D. E. M., Helzlsouer, K. J., Alberg, A. J., Hoffman, S., Hou, J., Daniel, R. W., Shah, K. V., & Major, E. O. (2003) · PubMed · Cited by 87
Self-citationRollison, D. E. M., Utaipat, U., Ryschkewitsch, C. F., Hou, J., Goldthwaite, P. T., Daniel, R. W., Helzlsouer, K. J., Burger, P. C., Shah, K. V., & Major, E. O. (2004) · International Journal of Cancer · doi:10.1002/ijc.20641 · Cited by 85
Self-citationIdentification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals
Chatterjee, M., Weyandt, T. B., & Frisque, R. J. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200003)60:3 · Cited by 85
Shah, K. V., Daniel, R. W., Strickler, H. D., & Goedert, J. J. (1997) · The Journal of Infectious Diseases · doi:10.1086/517340 · Cited by 83
Self-citationStrickler, H. D. (2001) · PubMed · Cited by 82
Serological evidence of SV40 infections in HIV-infected and HIV-negative adults
Jafar, S., Rodriguez‐Barradas, M. C., Graham, D. Y., & Butel, J. S. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199804)54:4 · Cited by 80
Meng, Q., Springall, D. R., Bishop, A. E., Morgan, K., Evans, T. J., Habib, S. B., Gruenert, D. C., Gyi, K. M., Hodson, M. E., Yacoub, M. H., et al. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199803)184:3 · Cited by 176
Comparing Phylogenetic Codivergence between Polyomaviruses and Their Hosts
Pérez‐Losada, M., Christensen, R. G., McClellan, D. A., Adams, B. J., Viscidi, R. P., Demma, J. C., & Crandall, K. A. (2006) · Journal of Virology · doi:10.1128/jvi.00056-06 · Cited by 80
Huang, S.-T., Skolasky, R. L., Pan, G. J. D., Royal, W., & McArthur, J. C. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114533 · Cited by 77
Detection of BK virus and simian virus 40 in the urine of healthy children
Vanchiere, J. A., White, Z. S., & Butel, J. S. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20287 · Cited by 74
Molecular and infectivity studies of porcine circovirus in vaccines
McClenahan, S. D., Krause, P. R., & Uhlenhaut, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.087 · Cited by 73
Molecular Evidence of Simian Virus 40 Infections in Children
Butel, J. S., Arrington, A. S., Wong, C. C., Lednicky, J. A., & Finegold, M. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314915 · Cited by 73
Evidence of SV40 infections in hospitalized children*1, *2, *3
Butel, J. S. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90173-9 · Cited by 72
Strickler, H. D., Goedert, J. J., Devesa, S. S., Lahey, J., Fraumeni, J. F., & Rosenberg, P. S. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.38 · Cited by 72
BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors
Barbanti‐Brodano, G., Sabbioni, S., Martini, F., Negrini, M., Corallini, A., & Tognon, M. G. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_23 · Cited by 72
Martini, F., Lazzarin, L., Iaccheri, L., Vignocchi, B., Finocchiaro, G., Magnani, I., Serra, M., Scotlandi, K., Barbanti‐Brodano, G., & Tognon, M. G. (2002) · Cancer · doi:10.1002/cncr.10272 · Cited by 71
Serological Cross Reactivity between Polyomavirus Capsids
Viscidi, R. P., & Clayman, B. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_5 · Cited by 70
Xenotransplantation and risks of zoonotic infections
Boneva, R. S., & Folks, T. M. (2004) · Annals of Medicine · doi:10.1080/07853890410018826 · Cited by 70
Mechanistic Bases for Adverse Vaccine Reactions and Vaccine Failures
Roth, J. A. (1999) · Advances in veterinary medicine · doi:10.1016/s0065-3519(99)80053-6 · Cited by 69
Human tumor suppressor p53 and DNA viruses
Collot-Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 69
Cell substrates for the production of viral vaccines
Aubrit, F., Perugi, F., Léon, A., Guéhenneux, F., Champion-Arnaud, P., Lahmar, M. M., & Schwamborn, K. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.110 · Cited by 65
Martini, F., Corallini, A., Balatti, V., Sabbioni, S., Pancaldi, C., & Tognon, M. G. (2007) · Infectious Agents and Cancer · doi:10.1186/1750-9378-2-13 · Cited by 61
Glucagon-like peptide-1 does not mediate amylase release from AR42J cells
Zhou, J., Montrose‐Rafizadeh, C., Janczewski, A. M., Piñeyro, M. A., Sollott, S. J., Wang, Y., & Egan, J. M. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199912)181:3 · Cited by 18
Delbue, S., Pagani, E., Guerini, F. R., Agliardi, C., Mancuso, R., Borghi, E., Rossi, F. M., Boldorini, R. L., Veggiani, C., Car, P. G., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20474 · Cited by 60
Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples
Kjærheim, K., Røe, O. D., Waterboer, T., Sehr, P. A., Rizk, R. Z., Dai, H. Y., Sandeck, H., Larsson, E., Andersen, A., Boffetta, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22592 · Cited by 60
The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma
Linton, A., Vardy, J. L., Clarke, S. J., & van Zandwijk, N. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.03.001 · Cited by 58
Yamamoto, H., Murakami, H., Hosaka, T., Nakamata, T., Oka, M., Toguchida, J., Tsuboyama, T., Nakamura, T., & Nakayama, T. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1213 · Cited by 58
Lednicky, J. A., & Butel, J. S. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114518 · Cited by 58
Strategies for Tailoring the Pore-Size Distribution of Virus Retention Filter Papers
Gustafsson, S., & Mihranyan, A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03093 · Cited by 59
SV40 As an Effective Gene Transfer Vector in Vivo
Strayer, D. S. (1996) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)40066-x · Cited by 56
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 55
Rollison, D. E. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh212 · Cited by 53
Sticking a Needle into Science: The Case of Polio Vaccines and the Origin of AIDS
Martin, B. G. (1996) · Social Studies of Science · doi:10.1177/030631296026002003 · Cited by 53
Human and animal vaccine contaminations
Pastoret, P.-P. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.02.015 · Cited by 52
Schwartz, J. L., Jordan, R. T., Liber, H. L., Murnane, J. P., & Evans, H. H. (2001) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999 · Cited by 27
Simian virus 40 sequences in malignant lymphomas in Japan.
Nakatsuka, S., Liu, A., Dong, Z., Nomura, S., Takakuwa, T., Miyazato, H., & Aozasa, K. (2003) · PubMed · Cited by 51
Cook, L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0010-2015 · Cited by 50
Tognon, M. G., Casalone, R., Martini, F., Mattei, M. D., Granata, P., Minelli, E., Arcuri, C., Collini, P., & Bocchini, V. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(96)00067-2 · Cited by 50
Dang‐Tan, T., Mahmud, S. M., Puntoni, R., & Franco, E. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207877 · Cited by 49
Brain Tumors and Polyomaviruses
Croul, S. E., Otte, J., & Khalili, K. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390194055 · Cited by 49
Progressive Multifocal Leukoencephalopathy
Peters, A. C. B. (1980) · Archives of Neurology · doi:10.1001/archneur.1980.00500570045006 · Cited by 48
Malignant Pleural Mesothelioma
Kaplan, N. M., Palmer, B. F., & Hughes, R. S. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200501000-00007 · Cited by 46
Simian virus 40 (SV40) and human cancer: a review of the serological data
Shah, K. V., Galloway, D. A., Knowles, W. A., & Viscidi, R. P. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.432 · Cited by 45
Self-citationAbsence of simian virus 40 in human brain tumors from northern India
Engels, E. A., Sarkar, C., Daniel, R. W., Gravitt, P. E., Verma, K., Quezado, M., & Shah, K. V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10621 · Cited by 45
Self-citationDoes SV40 infection contribute to the development of human cancers?
Shah, K. V. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200001/02)10:1 · Cited by 44
Self-citationInvestigation of porcine circovirus contamination in human vaccines
Gilliland, S. M., Forrest, L., Carré, H., Jenkins, A., Berry, N. J., Martín, J. E.-S., Minor, P. D., & Schepelmann, S. (2012) · Biologicals · doi:10.1016/j.biologicals.2012.02.002 · Cited by 43
Kidney, B. A., Haines, D. M., Ellis, J. A., Burnham, M. L., Teifke, J. P., Czerwinski, G., & Jackson, M. L. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.833 · Cited by 43
Carroll-Pankhurst, C., Engels, E. A., Strickler, H. D., Goedert, J. J., Wagner, J., & Mortimer, E. A. (2001) · British Journal of Cancer · doi:10.1038/sj/bjc/6692065 · Cited by 42
An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication
Minor, P. D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3292-4_1 · Cited by 41
Burton, G. J., & Watson, A. L. (1997) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199712)7:4 · Cited by 52
Polyomavirus in Human Cancer Development
Lee, W., & Langhoff, E. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_22 · Cited by 41
Immunity and Autoimmunity Induced by Polyomaviruses
Rekvig, O. P., Bendiksen, S., & Moens, U. L. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_9 · Cited by 41
Case-Control Study of Simian Virus 40 and Non-Hodgkin Lymphoma in the United States
Engels, E. A., Viscidi, R. P., Galloway, D. A., Carter, J. J., Cerhan, J. R., Davis, S. M., Cozen, W., Severson, R. K., de Sanjosé, S., Colt, J. S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh266 · Cited by 41
Isolation of a SV40‐like papovavirus from a human glioblastoma
Scherneck, S., Rudolph, M., Geißler, E., Vogel, F., van der Lubbe, L. J. M., Wählte, H., Nisch, G., Weickmann, F., & Zimmermann, W. (1979) · International Journal of Cancer · doi:10.1002/ijc.2910240502 · Cited by 41
Serodiagnosis for Tumor Viruses
Morrison, B. J., Labò, N., Miley, W., & Whitby, D. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.024 · Cited by 41
Studies of neutralising antibodies to SV40 in human sera
Minor, P. D., Pipkin, P. A., Jarzebek, Z., & Knowles, W. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10422 · Cited by 40
Serologic Evidence for Exposure to Simian Virus 40 in North American Zoo Workers
Engels, E. A., Switzer, W. M., Heneine, W., & Viscidi, R. P. (2004) · The Journal of Infectious Diseases · doi:10.1086/425997 · Cited by 40
Epidemiologic Studies of Polyomaviruses and Cancer
Rollison, D. E. M. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_24 · Cited by 39
Martin, B. G. (2010) · Science as Culture · doi:10.1080/09505430903186088 · Cited by 39
Hübner, R., & Marck, E. V. (2002) · Cancer Causes & Control · doi:10.1023/a:1014321729038 · Cited by 39
Simian virus 40 and human pleural mesothelioma
Jasani, B., Rudd, R., & Mulatero, C. (1999) · Thorax · doi:10.1136/thx.54.8.750b · Cited by 39
A Prospective Longitudinal Study of Polyomavirus Shedding in Lung‐Transplant Recipients
Thomas, L. D., Vilchez, R. A., White, Z. S., Zanwar, P., Milstone, A. P., Butel, J. S., & Dummer, S. J. (2007) · The Journal of Infectious Diseases · doi:10.1086/510625 · Cited by 38
Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus monkeys
Newman, J. S., Baskin, G. B., & Frisque, R. J. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114538 · Cited by 37
Gregersen, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.076 · Cited by 36
An update on nonmelanoma skin cancer.
Patel, R. V., Frankel, A. J., & Goldenberg, G. (2011) · PubMed Central · Cited by 35
Metadata
- Authors
- SHAH, K., & NATHANSON, N.
- Corresponding author
- SHAH, KEERTI
- ORCID
- NATHANSON, NEAL
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1976-01
- Volume
- 103
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2158307330
- Cited by
- 339
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 22 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 9 · 2013: 8 · 2012: 12
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- simian virus 40, human exposure, viral oncogenesis, retroviruses
- MeSH terms
- Adult, Aged, Animals, Antibodies, Viral, Antigens, Neoplasm, Child, Disease Reservoirs, Female, Follow-Up Studies, Humans, Immunization, Infant, Newborn, Leukoencephalopathy, Progressive Multifocal, Middle Aged, Neoplasms, Oncogenic Viruses, Poliovirus Vaccine, Inactivated, Population Surveillance, Pregnancy, Prospective Studies, Retrospective Studies, Simian virus 40, Virus Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review